Associations between parents’ satisfaction with provider communication and HPV vaccination behaviors

Melanie L. Kornides, Holly B. Fontenot, Annie-Laurie McRee, Catherine A. Panozzo, Melissa B. Gilkey

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Despite increasing awareness of the importance of a provider recommendation for HPV vaccine, the U.S. has yet to achieve the Healthy people 2020 goal of 80% series completion among adolescents. This failure indicates a need for further examination of the modifiable influences on parents’ decision-making. Healthcare providers can influence parents’ HPV vaccination decision-making, but little is known about parents’ perspectives on the counseling they receive. We sought to assess U.S. parents’ satisfaction with provider communication about HPV vaccine and associations with vaccination behaviors. Methods: Parents of 11-to-17-year-old adolescents who discussed HPV vaccination with a healthcare provider at least once (n = 795) completed our online survey in Fall 2016. We assessed their satisfaction with the discussion using the HPV Vaccine Communication Satisfaction Scale (α = 0.94). We examined associations between satisfaction (categorized as low, moderate, or high), and three vaccination behaviors: refusal/delay, series initiation (≥1 dose), and continuation (≥2 doses among initiators) using multivariable logistic regression. Results: Most parents reported high (36%) or moderate (38%) satisfaction with provider communication about HPV vaccination; fewer reported low (26%) satisfaction. Moderately satisfied parents (vs. low) had lower odds of refusal/delay (aOR = 0.59, 95% CI: 0.38–0.89), and higher odds of initiation (aOR = 1.71, 95% CI:1.15–2.55) and continuation (aOR = 2.05, 95% CI: 1.24–3.40). The associations were stronger for highly satisfied parents (refusal/delay aOR = 0.45, 95% CI: 0.29–0.70, initiation aOR = 3.59, 95% CI: 2.23–5.78, and continuation aOR = 4.08, 95% CI: 2.38–7.01). Conclusions: Our study suggests that parent satisfaction with provider communication may play an important role in HPV vaccination decision-making. Yet, communication satisfaction has been largely unexamined in the HPV-vaccine literature to date. We introduce a brief, 7-item HPV Vaccine Communication Scale that can be used to assess parents’ level of satisfaction with their provider's communication specific to HPV vaccine. We identify communication areas for providers to prioritize when discussing HPV vaccine with parents.

Original languageEnglish (US)
Pages (from-to)2637-2642
Number of pages6
JournalVaccine
Volume36
Issue number19
DOIs
StatePublished - May 3 2018

Fingerprint

communication (human)
Papillomavirus Vaccines
Vaccination
Parents
Communication
vaccination
vaccines
animal communication
decision making
health services
Decision Making
Health Personnel
counseling
dosage
Counseling
Logistic Models

Keywords

  • Adolescent health
  • Cancer prevention
  • HPV vaccination
  • Parents
  • Patient education and counseling

PubMed: MeSH publication types

  • Journal Article
  • Research Support, N.I.H., Extramural

Cite this

Associations between parents’ satisfaction with provider communication and HPV vaccination behaviors. / Kornides, Melanie L.; Fontenot, Holly B.; McRee, Annie-Laurie; Panozzo, Catherine A.; Gilkey, Melissa B.

In: Vaccine, Vol. 36, No. 19, 03.05.2018, p. 2637-2642.

Research output: Contribution to journalArticle

Kornides, Melanie L. ; Fontenot, Holly B. ; McRee, Annie-Laurie ; Panozzo, Catherine A. ; Gilkey, Melissa B. / Associations between parents’ satisfaction with provider communication and HPV vaccination behaviors. In: Vaccine. 2018 ; Vol. 36, No. 19. pp. 2637-2642.
@article{6c8d07170f834532b33645b8766c2e0e,
title = "Associations between parents’ satisfaction with provider communication and HPV vaccination behaviors",
abstract = "Background: Despite increasing awareness of the importance of a provider recommendation for HPV vaccine, the U.S. has yet to achieve the Healthy people 2020 goal of 80{\%} series completion among adolescents. This failure indicates a need for further examination of the modifiable influences on parents’ decision-making. Healthcare providers can influence parents’ HPV vaccination decision-making, but little is known about parents’ perspectives on the counseling they receive. We sought to assess U.S. parents’ satisfaction with provider communication about HPV vaccine and associations with vaccination behaviors. Methods: Parents of 11-to-17-year-old adolescents who discussed HPV vaccination with a healthcare provider at least once (n = 795) completed our online survey in Fall 2016. We assessed their satisfaction with the discussion using the HPV Vaccine Communication Satisfaction Scale (α = 0.94). We examined associations between satisfaction (categorized as low, moderate, or high), and three vaccination behaviors: refusal/delay, series initiation (≥1 dose), and continuation (≥2 doses among initiators) using multivariable logistic regression. Results: Most parents reported high (36{\%}) or moderate (38{\%}) satisfaction with provider communication about HPV vaccination; fewer reported low (26{\%}) satisfaction. Moderately satisfied parents (vs. low) had lower odds of refusal/delay (aOR = 0.59, 95{\%} CI: 0.38–0.89), and higher odds of initiation (aOR = 1.71, 95{\%} CI:1.15–2.55) and continuation (aOR = 2.05, 95{\%} CI: 1.24–3.40). The associations were stronger for highly satisfied parents (refusal/delay aOR = 0.45, 95{\%} CI: 0.29–0.70, initiation aOR = 3.59, 95{\%} CI: 2.23–5.78, and continuation aOR = 4.08, 95{\%} CI: 2.38–7.01). Conclusions: Our study suggests that parent satisfaction with provider communication may play an important role in HPV vaccination decision-making. Yet, communication satisfaction has been largely unexamined in the HPV-vaccine literature to date. We introduce a brief, 7-item HPV Vaccine Communication Scale that can be used to assess parents’ level of satisfaction with their provider's communication specific to HPV vaccine. We identify communication areas for providers to prioritize when discussing HPV vaccine with parents.",
keywords = "Adolescent health, Cancer prevention, HPV vaccination, Parents, Patient education and counseling",
author = "Kornides, {Melanie L.} and Fontenot, {Holly B.} and Annie-Laurie McRee and Panozzo, {Catherine A.} and Gilkey, {Melissa B.}",
year = "2018",
month = "5",
day = "3",
doi = "10.1016/j.vaccine.2018.03.060",
language = "English (US)",
volume = "36",
pages = "2637--2642",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "19",

}

TY - JOUR

T1 - Associations between parents’ satisfaction with provider communication and HPV vaccination behaviors

AU - Kornides, Melanie L.

AU - Fontenot, Holly B.

AU - McRee, Annie-Laurie

AU - Panozzo, Catherine A.

AU - Gilkey, Melissa B.

PY - 2018/5/3

Y1 - 2018/5/3

N2 - Background: Despite increasing awareness of the importance of a provider recommendation for HPV vaccine, the U.S. has yet to achieve the Healthy people 2020 goal of 80% series completion among adolescents. This failure indicates a need for further examination of the modifiable influences on parents’ decision-making. Healthcare providers can influence parents’ HPV vaccination decision-making, but little is known about parents’ perspectives on the counseling they receive. We sought to assess U.S. parents’ satisfaction with provider communication about HPV vaccine and associations with vaccination behaviors. Methods: Parents of 11-to-17-year-old adolescents who discussed HPV vaccination with a healthcare provider at least once (n = 795) completed our online survey in Fall 2016. We assessed their satisfaction with the discussion using the HPV Vaccine Communication Satisfaction Scale (α = 0.94). We examined associations between satisfaction (categorized as low, moderate, or high), and three vaccination behaviors: refusal/delay, series initiation (≥1 dose), and continuation (≥2 doses among initiators) using multivariable logistic regression. Results: Most parents reported high (36%) or moderate (38%) satisfaction with provider communication about HPV vaccination; fewer reported low (26%) satisfaction. Moderately satisfied parents (vs. low) had lower odds of refusal/delay (aOR = 0.59, 95% CI: 0.38–0.89), and higher odds of initiation (aOR = 1.71, 95% CI:1.15–2.55) and continuation (aOR = 2.05, 95% CI: 1.24–3.40). The associations were stronger for highly satisfied parents (refusal/delay aOR = 0.45, 95% CI: 0.29–0.70, initiation aOR = 3.59, 95% CI: 2.23–5.78, and continuation aOR = 4.08, 95% CI: 2.38–7.01). Conclusions: Our study suggests that parent satisfaction with provider communication may play an important role in HPV vaccination decision-making. Yet, communication satisfaction has been largely unexamined in the HPV-vaccine literature to date. We introduce a brief, 7-item HPV Vaccine Communication Scale that can be used to assess parents’ level of satisfaction with their provider's communication specific to HPV vaccine. We identify communication areas for providers to prioritize when discussing HPV vaccine with parents.

AB - Background: Despite increasing awareness of the importance of a provider recommendation for HPV vaccine, the U.S. has yet to achieve the Healthy people 2020 goal of 80% series completion among adolescents. This failure indicates a need for further examination of the modifiable influences on parents’ decision-making. Healthcare providers can influence parents’ HPV vaccination decision-making, but little is known about parents’ perspectives on the counseling they receive. We sought to assess U.S. parents’ satisfaction with provider communication about HPV vaccine and associations with vaccination behaviors. Methods: Parents of 11-to-17-year-old adolescents who discussed HPV vaccination with a healthcare provider at least once (n = 795) completed our online survey in Fall 2016. We assessed their satisfaction with the discussion using the HPV Vaccine Communication Satisfaction Scale (α = 0.94). We examined associations between satisfaction (categorized as low, moderate, or high), and three vaccination behaviors: refusal/delay, series initiation (≥1 dose), and continuation (≥2 doses among initiators) using multivariable logistic regression. Results: Most parents reported high (36%) or moderate (38%) satisfaction with provider communication about HPV vaccination; fewer reported low (26%) satisfaction. Moderately satisfied parents (vs. low) had lower odds of refusal/delay (aOR = 0.59, 95% CI: 0.38–0.89), and higher odds of initiation (aOR = 1.71, 95% CI:1.15–2.55) and continuation (aOR = 2.05, 95% CI: 1.24–3.40). The associations were stronger for highly satisfied parents (refusal/delay aOR = 0.45, 95% CI: 0.29–0.70, initiation aOR = 3.59, 95% CI: 2.23–5.78, and continuation aOR = 4.08, 95% CI: 2.38–7.01). Conclusions: Our study suggests that parent satisfaction with provider communication may play an important role in HPV vaccination decision-making. Yet, communication satisfaction has been largely unexamined in the HPV-vaccine literature to date. We introduce a brief, 7-item HPV Vaccine Communication Scale that can be used to assess parents’ level of satisfaction with their provider's communication specific to HPV vaccine. We identify communication areas for providers to prioritize when discussing HPV vaccine with parents.

KW - Adolescent health

KW - Cancer prevention

KW - HPV vaccination

KW - Parents

KW - Patient education and counseling

UR - http://www.scopus.com/inward/record.url?scp=85044867014&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044867014&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2018.03.060

DO - 10.1016/j.vaccine.2018.03.060

M3 - Article

VL - 36

SP - 2637

EP - 2642

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 19

ER -